# Eli Lilly to buy Ajax Therapeutics for up to $2.3B in cash.

*biotech · news · 2026-04-27 · Seeking Alpha*

## Key points

- Eli Lilly will acquire Ajax Therapeutics for up to $2.3 billion in cash.
- The deal includes an upfront payment plus milestone-based clinical and regulatory payments.
- This acquisition targets Ajax’s biopharmaceutical assets to expand Lilly’s portfolio.
- Milestone payments depend on specified clinical and regulatory achievements.

**Companies:** Eli Lilly and Company

[Read the full story on Seeking Alpha](https://seekingalpha.com/news/4579855-eli-lilly-to-buy-ajax-therapeutics-for-up-to-23b-in-cash)

---

Canonical: https://newsio.io/n/66d4b0c2-6f96-4d97-8f1e-cb29548b5a5c/eli-lilly-to-buy-ajax-therapeutics-for-up-to-2-3b-in-cash
Summarized by Newsio from Seeking Alpha. https://newsio.io/how-it-works